Liver damage favors the eliminations of HBV integration and clonal hepatocytes in chronic hepatitis B

BACKGROUND: HBV integration is suspected to be an obstinate risk factor for hepatocellular carcinoma (HCC) in the era of antiviral therapy. Integration events start to occur in the immunotolerance phase, but their fates in the immune clearance phase have not yet been clarified. Here, we report the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Gang, Huang, Ming X., Li, Wei Y., Gan, Chong J., Dong, Wen X., Peng, Xiao M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886763/
https://www.ncbi.nlm.nih.gov/pubmed/33534083
http://dx.doi.org/10.1007/s12072-020-10125-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886763/
https://www.ncbi.nlm.nih.gov/pubmed/33534083
http://dx.doi.org/10.1007/s12072-020-10125-y

Ejemplares similares